Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (NY: THNR )

22.10 -0.29 (-1.30%)
Streaming Delayed Price Updated: 1:45 PM EDT, Mar 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 469
Open 22.35
Bid (Size) 22.22 (20)
Ask (Size) 22.44 (12)
Prev. Close 22.39
Today's Range 22.10 - 22.35
52wk Range 22.00 - 28.19
Shares Outstanding 1,800
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Recently, the company announced a massive $15 billion share buyback plan and a 15% dividend increase. 
Via Benzinga
Topics ETFs
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry. 
Via Benzinga

Performance

YTD
-2.33%
-2.33%
1 Month
-3.91%
-3.91%
3 Month
-9.32%
-9.32%
6 Month
-18.30%
-18.30%
1 Year
-12.99%
-12.99%

More News

Read More
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
Via Benzinga
Topics ETFs
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.